VCT220
A Research Study of VCT220 in Adult Chinese Participants With Obesity
Vincentage Pharma Co · Phase 3 · Completed · Enrollment 840
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| High dose group | n/r | n/r | n/r | n/r |
| Moderate dose group | n/r | n/r | n/r | n/r |
| Placebo group | n/r | n/r | n/r | n/r |
Not shown
- High dose group: endpoint not reported
- Moderate dose group: endpoint not reported
- Placebo group: endpoint not reported